Diffusion tensor and postcontrast T1-weighted imaging radiomics to differentiate the epidermal growth factor receptor mutation status of brain metastases from non-small cell lung cancer

被引:25
|
作者
Park, Yae Won [1 ,2 ,3 ]
An, Chansik [4 ]
Lee, JaeSeong [5 ]
Han, Kyunghwa [1 ,2 ,3 ]
Choi, Dongmin [6 ]
Ahn, Sung Soo [1 ,2 ,3 ]
Kim, Hwiyoung [1 ,2 ,3 ]
Ahn, Sung Jun [7 ]
Chang, Jong Hee [8 ]
Kim, Se Hoon [9 ]
Lee, Seung-Koo [1 ,2 ,3 ]
机构
[1] Yonsei Univ, Coll Med, Dept Radiol, 50-1 Yonsei Ro, Seoul 03722, South Korea
[2] Yonsei Univ, Coll Med, Res Inst Radiol Sci, 50-1 Yonsei Ro, Seoul 03722, South Korea
[3] Yonsei Univ, Coll Med, Ctr Clin Imaging Data Sci, 50-1 Yonsei Ro, Seoul 03722, South Korea
[4] Natl Hlth Insurance Serv Ilsan Hosp, Res & Anal Team, Goyang, South Korea
[5] Yonsei Univ, Dept Mech Engn, Seoul, South Korea
[6] Yonsei Univ, Dept Comp Sci, Seoul, South Korea
[7] Yonsei Univ, Gangnam Severance Hosp, Dept Radiol, Coll Med, Seoul, South Korea
[8] Yonsei Univ, Dept Neurosurg, Coll Med, Seoul, South Korea
[9] Yonsei Univ, Dept Pathol, Coll Med, Seoul, South Korea
基金
新加坡国家研究基金会;
关键词
Epidermal growth factor receptor; Imaging; Diffusion tensor; Machine learning; Magnetic resonance imaging; Radiomics; TUMORS; FEATURES; PROGRESSION; DIAGNOSIS; SURVIVAL; TEXTURE; LESIONS; GENE;
D O I
10.1007/s00234-020-02529-2
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Purpose To assess whether the radiomic features of diffusion tensor imaging (DTI) and conventional postcontrast T1-weighted (T1C) images can differentiate the epidermal growth factor receptor (EGFR) mutation status in brain metastases from non-small cell lung cancer (NSCLC). Methods A total of 99 brain metastases in 51 patients who underwent surgery or biopsy with underlying NSCLC and known EGFR mutation statuses (57 from EGFR wild type, 42 from EGFR mutant) were allocated to the training (57 lesions in 31 patients) and test (42 lesions in 20 patients) sets. Radiomic features (n= 526) were extracted from preoperative MR images including T1C and DTI. Radiomics classifiers were constructed by combinations of five feature selectors and four machine learning algorithms. The trained classifiers were validated on the test set, and the classifier performance was assessed by determining the area under the curve (AUC). Results EGFR mutation status showed an overall discordance rate of 12% between the primary tumors and corresponding brain metastases. The best performing classifier was a combination of the tree-based feature selection and linear discriminant algorithm and 5 features were selected (1 from ADC, 2 from fractional anisotropy, and 2 from T1C images), resulting in an AUC, accuracy, sensitivity, and specificity of 0.73, 78.6%, 81.3%, and 76.9% in the test set, respectively. Conclusions Radiomics classifiers integrating multiparametric MRI parameters may have potential in differentiating the EGFR mutation status in brain metastases from NSCLC.
引用
收藏
页码:343 / 352
页数:10
相关论文
共 50 条
  • [1] Diffusion tensor and postcontrast T1-weighted imaging radiomics to differentiate the epidermal growth factor receptor mutation status of brain metastases from non-small cell lung cancer
    Yae Won Park
    Chansik An
    JaeSeong Lee
    Kyunghwa Han
    Dongmin Choi
    Sung Soo Ahn
    Hwiyoung Kim
    Sung Jun Ahn
    Jong Hee Chang
    Se Hoon Kim
    Seung-Koo Lee
    Neuroradiology, 2021, 63 : 343 - 352
  • [2] Epidermal growth factor receptor mutations and brain metastases in non-small cell lung cancer
    Zhao, Wei
    Zhou, Wei
    Rong, Li
    Sun, Mao
    Lin, Xing
    Wang, Lulu
    Wang, Shiqiang
    Wang, Ying
    Hui, Zhouguang
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [3] Using Radiomics to Differentiate Brain Metastases From Lung Cancer Versus Breast Cancer, Including Predicting Epidermal Growth Factor Receptor and human Epidermal Growth Factor Receptor 2 Status
    Shi, Jiaxin
    Chen, Huanhuan
    Wang, Xiaoyu
    Cao, Ran
    Chen, Yu
    Cheng, Yuan
    Pang, Ziyan
    Huang, Chao
    JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 2023, 47 (06) : 924 - 933
  • [4] Epidermal growth factor receptor mutation and pattern of brain metastasis in patients with non-small cell lung cancer
    Baek, Min Young
    Ahn, Hee Kyung
    Park, Kyu Ree
    Park, Hwa-Sun
    Kang, Shin Myung
    Park, Inkeun
    Kim, Young Saing
    Hong, Junshik
    Sym, Sun Jin
    Park, Jinny
    Lee, Jae Hoon
    Shin, Dong Bok
    Cho, Eun Kyung
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2018, 33 (01) : 168 - 175
  • [5] Contrast-enhanced T1-weighted image radiomics of brain metastases may predict EGFR mutation status in primary lung cancer
    Ahn, Sung Jun
    Kwon, Hyeokjin
    Yang, Jin-Ju
    Park, Mina
    Cha, Yoon Jin
    Suh, Sang Hyun
    Lee, Jong-Min
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [6] Predicting Survival Duration With MRI Radiomics of Brain Metastases From Non-small Cell Lung Cancer
    Chen, Bihong T.
    Jin, Taihao
    Ye, Ningrong
    Mambetsariev, Isa
    Wang, Tao
    Wong, Chi Wah
    Chen, Zikuan
    Rockne, Russell C.
    Colen, Rivka R.
    Holodny, Andrei I.
    Sampath, Sagus
    Salgia, Ravi
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [7] The Role of Mutation Status of the Epidermal Growth Factor Receptor Gene In Advanced Non-Small Cell Lung Cancer
    Vaguliene, Neringa
    Zemaitis, Marius
    Sarauskas, Valdas
    Vitkauskiene, Astra
    Miliauskas, Skaidrius
    MEDICINA-LITHUANIA, 2012, 48 (04): : 175 - 181
  • [8] Epidermal Growth Factor Receptor Mutation Status in the Treatment of Non-small Cell Lung Cancer: Lessons Learned
    Lee, Dae Ho
    Srimuninnimit, Vichien
    Cheng, Rebecca
    Wang, Xin
    Orlando, Mauro
    CANCER RESEARCH AND TREATMENT, 2015, 47 (04): : 549 - 554
  • [9] EGFR mutation status on brain metastases from non-small cell lung cancer
    Hsu, Fred
    De Caluwe, Alex
    Anderson, David
    Nichol, Alan
    Toriumi, Ted
    Ho, Cheryl
    LUNG CANCER, 2016, 96 : 101 - 107
  • [10] Different spatial distributions of brain metastases from lung cancer by histological subtype and mutation status of epidermal growth factor receptor
    Takano, Koji
    Kinoshita, Manabu
    Takagaki, Masatoshi
    Sakai, Mio
    Tateishi, Souichirou
    Achiha, Takamune
    Hirayama, Ryuichi
    Nishino, Kazumi
    Uchida, Junji
    Kumagai, Toru
    Okami, Jiro
    Kawaguchi, Atsushi
    Hashimoto, Naoya
    Nakanishi, Katsuyuki
    Imamura, Fumio
    Higashiyama, Masahiko
    Yoshimine, Toshiki
    NEURO-ONCOLOGY, 2016, 18 (05) : 716 - 724